| RS2486985503 |
RPS20
|
Health Risk |
Likely pathogenic |
— |
| RS2486986598 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486987142 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486987213 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486987392 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486987534 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2486987573 |
ANK1
|
Health Risk |
Likely pathogenic |
ANK1-related disorder, ANK1-related disorder |
| RS2486987938 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486988302 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486988534 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486993028 |
DDHD2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia 54 |
| RS2486996437 |
GATA4
|
Health Risk |
Pathogenic |
Atrioventricular septal defect 4, Atrioventricular septal defect 4 |
| RS2486997282 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486997285 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486997376 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2486997588 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2486998975 |
RHOBTB2
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2486999040 |
RHOBTB2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 64 |
| RS2486999107 |
RHOBTB2
|
Health Risk |
Pathogenic |
RHOBTB2-related disorder, RHOBTB2-related disorder |
| RS2486999855 |
DDHD2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia 54 |
| RS2487001941 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487001985 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487002050 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487002864 |
HGSNAT
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2487003169 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487003212 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487009371 |
IKBKB
|
Health Risk |
Likely pathogenic |
IKBKB-related disorder, IKBKB-related disorder |
| RS2487010539 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2487015049 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487015109 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487015299 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487015403 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487015952 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487025773 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487027092 |
THAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS2487029590 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487030075 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487030414 |
THAP1
|
Health Risk |
Likely pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS2487030539 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS2487030586 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS2487030639 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS2487031587 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487031771 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487033881 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487034068 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487034267 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487034928 |
MOS
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 20, Oocyte/zygote/embryo maturation arrest 20 |
| RS2487034940 |
MOS
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 20, Oocyte/zygote/embryo maturation arrest 20 |
| RS2487035279 |
MOS
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 20, Oocyte/zygote/embryo maturation arrest 20 |
| RS2487035768 |
MOS
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 20, Oocyte/zygote/embryo maturation arrest 20 |
| RS2487036103 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487036131 |
MOS
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 20, Oocyte/zygote/embryo maturation arrest 20 |
| RS2487036236 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487036360 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487036515 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487039629 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487042104 |
THAP1
|
Health Risk |
Likely pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS2487042279 |
THAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Torsion dystonia 6, Torsion dystonia 6 |
| RS2487042330 |
THAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS2487050998 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2487056938 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487057016 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487057516 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487058978 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487059083 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487059108 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS2487059186 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487059203 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487059295 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487060422 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487060716 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS2487061701 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS2487061977 |
KAT6A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2487062128 |
KAT6A
|
Health Risk |
Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS2487062209 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487062211 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487062310 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487062427 |
KAT6A
|
Health Risk |
Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS2487063127 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487063325 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS2487063377 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487063393 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487064604 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487064738 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487064869 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487065042 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487067183 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS2487067364 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487067543 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487067594 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487067650 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487068851 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS2487069210 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487069265 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS2487069292 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS2487074150 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS2487074342 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS2487076683 |
SLC20A2
|
Health Risk |
Likely pathogenic |
— |
| RS2487082521 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487082948 |
BPNT2
|
Health Risk |
Likely pathogenic |
Chondrodysplasia with joint dislocations, gPAPP type |